QUETIAPINE

QUETIAPINE was reported 194380 times

QUETIAPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PROLACTIN ABNORMAL 535 0.6199
1 ANOSOGNOSIA 460 0.5990
2 GRIP STRENGTH 136 0.5939
3 LUPUS VULGARIS 689 0.5468
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 950 0.4743
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 303 0.4536
6 STUBBORNNESS 174 0.4037
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 801 0.3862
8 SWOLLEN JOINT COUNT INCREASED 1202 0.3766
9 HYPOCHOLESTEROLAEMIA 132 0.3739
10 C-REACTIVE PROTEIN 333 0.3592
11 RETINITIS 599 0.3464
12 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 235 0.3401
13 DISLOCATION OF VERTEBRA 773 0.3386
14 RHEUMATIC FEVER 1458 0.3268
15 DIABETIC COMA 886 0.3161
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 175 0.3119
17 X-RAY ABNORMAL 500 0.2793
18 RHEUMATOID FACTOR POSITIVE 1517 0.2624
19 MULTIPLE DRUG THERAPY 187 0.2480
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1760 0.2454
21 BEZOAR 336 0.2435
22 NEUROLEPTIC MALIGNANT SYNDROME 2804 0.2362
23 DUODENAL ULCER PERFORATION 1691 0.2272
24 METABOLIC SYNDROME 371 0.2257
25 ANTICHOLINERGIC SYNDROME 351 0.2202
26 FACET JOINT SYNDROME 715 0.2194
27 SERONEGATIVE ARTHRITIS 249 0.2173
28 COGWHEEL RIGIDITY 226 0.2152
29 PERIPHERAL VENOUS DISEASE 864 0.2114
30 DISTURBANCE IN SOCIAL BEHAVIOUR 491 0.2082
31 PEMPHIGUS 2587 0.2067
32 SCHIZOAFFECTIVE DISORDER 367 0.2056
33 SOPOR 2539 0.1914
34 MUSCLE INJURY 1540 0.1857
35 PORPHYRIA ACUTE 263 0.1833
36 PSYCHIATRIC DECOMPENSATION 358 0.1830
37 GESTATIONAL DIABETES 854 0.1790
38 TYPE 2 DIABETES MELLITUS 6026 0.1788
39 TEMPERATURE REGULATION DISORDER 390 0.1749
40 DIABETIC NEUROPATHY 852 0.1719
41 OBESITY 2684 0.1683
42 HELICOBACTER INFECTION 1727 0.1679
43 KETOACIDOSIS 1215 0.1622
44 HYPOMANIA 593 0.1611
45 DISINHIBITION 258 0.1601
46 HAND DEFORMITY 2087 0.1590
47 BIPOLAR DISORDER 1630 0.1498
48 RESPIRATORY DISORDER NEONATAL 242 0.1492
49 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 962 0.1480
50 BIPOLAR I DISORDER 324 0.1475
51 SLEEP-RELATED EATING DISORDER 138 0.1473
52 PLEUROTHOTONUS 132 0.1460
53 OCULOGYRIC CRISIS 307 0.1429
54 FOLLICULITIS 1487 0.1417
55 AGITATION NEONATAL 134 0.1397
56 SCHIZOPHRENIA 1695 0.1393
57 C-REACTIVE PROTEIN ABNORMAL 875 0.1363
58 TYPE 1 DIABETES MELLITUS 803 0.1332
59 PERICARDITIS 2176 0.1294
60 CATATONIA 679 0.1292
61 DIABETIC COMPLICATION 329 0.1291
62 PRIAPISM 441 0.1278
63 EMOTIONAL POVERTY 223 0.1271
64 BONE EROSION 449 0.1268
65 HALLUCINATIONS, MIXED 529 0.1257
66 PARKINSONISM 1224 0.1254
67 HYPERCHOLESTEROLAEMIA 1210 0.1252
68 BREAST CANCER STAGE III 810 0.1249
69 METABOLIC DISORDER 718 0.1235
70 PSYCHOMOTOR SKILLS IMPAIRED 322 0.1228
71 TACHYPHRENIA 419 0.1209
72 SEDATION 3145 0.1200
73 PERSECUTORY DELUSION 293 0.1174
74 PSYCHOTIC SYMPTOM 240 0.1162
75 SEDATION COMPLICATION 295 0.1155
76 PRESCRIBED OVERDOSE 2231 0.1152
77 SUSPECTED SUICIDE 540 0.1151
78 MANIA 1861 0.1130
79 DEMENTIA ALZHEIMER'S TYPE 187 0.1120
80 HYPOTONIA NEONATAL 175 0.1120
81 LIP DRY 999 0.1099
82 DIABETES MELLITUS 8366 0.1096
83 GLOSSODYNIA 2455 0.1095
84 AKATHISIA 1491 0.1092
85 DELUSION 1685 0.1084
86 SYNOVITIS 1946 0.1078
87 LIVER INJURY 2621 0.1067
88 PSYCHOMOTOR RETARDATION 299 0.1063
89 WOUND INFECTION 1165 0.1063
90 INTENTIONAL SELF-INJURY 2148 0.1062
91 AUTOIMMUNE DISORDER 1019 0.1044
92 DRUG TOLERANCE DECREASED 291 0.1035
93 SUICIDE ATTEMPT 6269 0.1033
94 GLYCOSURIA 139 0.1028
95 JOINT RANGE OF MOTION DECREASED 1374 0.1023
96 POISONING DELIBERATE 967 0.1019
97 JOINT DESTRUCTION 158 0.1015
98 BRADYKINESIA 592 0.1002
99 BURSITIS 1206 0.0993
100 DIABETES MELLITUS NON-INSULIN-DEPENDENT 144 0.0990
101 COMA SCALE ABNORMAL 287 0.0990
102 DEREALISATION 213 0.0989
103 ANTIPSYCHOTIC DRUG LEVEL INCREASED 278 0.0987
104 MUSCLE RIGIDITY 1169 0.0977
105 HALLUCINATION, AUDITORY 1546 0.0972
106 PSYCHOTIC DISORDER 2813 0.0952
107 SEROTONIN SYNDROME 1787 0.0929
108 WOUND 2578 0.0921
109 IMPULSE-CONTROL DISORDER 189 0.0917
110 GRIP STRENGTH DECREASED 804 0.0913
111 FOETAL DEATH 473 0.0911
112 HYPERREFLEXIA 317 0.0909
113 DEPRESSIVE SYMPTOM 317 0.0898
114 HYPERAMMONAEMIC ENCEPHALOPATHY 156 0.0897
115 COMPLETED SUICIDE 7371 0.0884
116 OBSESSIVE-COMPULSIVE DISORDER 705 0.0878
117 STUPOR 282 0.0877
118 LIVE BIRTH 734 0.0877
119 BRADYPHRENIA 571 0.0873
120 ACCIDENTAL DEATH 162 0.0871
121 PARANOIA 1488 0.0862
122 FIBROMYALGIA 2077 0.0854
123 DYSTONIA 1644 0.0847
124 SUICIDAL BEHAVIOUR 348 0.0836
125 INTENTIONAL OVERDOSE 5324 0.0829
126 BLOOD PROLACTIN INCREASED 384 0.0814
127 HOMICIDAL IDEATION 330 0.0813
128 HYPERKINESIA 172 0.0811
129 IRRITABLE BOWEL SYNDROME 1727 0.0805
130 DISORGANISED SPEECH 147 0.0797
131 DELIRIUM 2756 0.0793
132 HYPERLIPIDAEMIA 945 0.0790
133 LOGORRHOEA 277 0.0785
134 ALCOHOL ABUSE 207 0.0773
135 BLEPHAROSPASM 481 0.0763
136 HYPERPROLACTINAEMIA 495 0.0763
137 BLOOD CHOLESTEROL INCREASED 3537 0.0758
138 ELECTROCARDIOGRAM QT PROLONGED 2711 0.0753
139 DIABETIC NEPHROPATHY 164 0.0744
140 POSTURE ABNORMAL 242 0.0743
141 BRADYPNOEA 199 0.0737
142 MAJOR DEPRESSION 536 0.0733
143 PERSONALITY DISORDER 190 0.0725
144 PANCREATITIS 3814 0.0721
145 DEPRESSION SUICIDAL 249 0.0719
146 CONTRAINDICATED PRODUCT ADMINISTERED 2165 0.0714
147 SYSTEMIC LUPUS ERYTHEMATOSUS 2531 0.0712
148 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 365 0.0711
149 SEXUAL DYSFUNCTION 830 0.0707
150 ACUTE PSYCHOSIS 174 0.0703
151 MULTIPLE DRUG OVERDOSE INTENTIONAL 226 0.0702
152 WALKING AID USER 463 0.0702
153 CLONUS 192 0.0701
154 DYSKINESIA 2850 0.0701
155 PULMONARY FIBROSIS 1341 0.0698
156 POISONING 873 0.0694
157 SCIATICA 1086 0.0681
158 ON AND OFF PHENOMENON 377 0.0678
159 TARDIVE DYSKINESIA 1915 0.0678
160 PERSONALITY CHANGE 629 0.0676
161 LOWER LIMB FRACTURE 1297 0.0674
162 FREEZING PHENOMENON 248 0.0669
163 AKINESIA 137 0.0661
164 DYSLIPIDAEMIA 335 0.0659
165 SUBSTANCE USE DISORDER 210 0.0659
166 LONG QT SYNDROME 158 0.0658
167 HALLUCINATION, VISUAL 1388 0.0657
168 TEARFULNESS 281 0.0653
169 EXOSTOSIS 596 0.0652
170 DEPRESSED LEVEL OF CONSCIOUSNESS 2568 0.0648
171 PANCREATITIS CHRONIC 153 0.0646
172 COMA 3064 0.0643
173 SINUS TACHYCARDIA 900 0.0633
174 DIABETES MELLITUS INADEQUATE CONTROL 1119 0.0631
175 PSORIATIC ARTHROPATHY 2561 0.0630
176 DRUG ABUSE 5195 0.0623
177 TORTICOLLIS 132 0.0622
178 EXTRAPYRAMIDAL DISORDER 1542 0.0620
179 TOXICITY TO VARIOUS AGENTS 10410 0.0617
180 PRESCRIBED UNDERDOSE 1231 0.0616
181 SOMNAMBULISM 405 0.0616
182 HALLUCINATION 4614 0.0612
183 SOCIAL AVOIDANT BEHAVIOUR 354 0.0611
184 MIOSIS 488 0.0607
185 AGGRESSION 3034 0.0606
186 INTENTIONAL DRUG MISUSE 1265 0.0604
187 SUBSTANCE ABUSE 491 0.0603
188 LUPUS-LIKE SYNDROME 547 0.0603
189 DIABETIC KETOACIDOSIS 1436 0.0597
190 GALACTORRHOEA 384 0.0597
191 POST-TRAUMATIC STRESS DISORDER 396 0.0590
192 RESTLESS LEGS SYNDROME 1071 0.0588
193 SELF INJURIOUS BEHAVIOUR 179 0.0586
194 ALCOHOL POISONING 157 0.0586
195 JOINT DISLOCATION 619 0.0585
196 SMALL FOR DATES BABY 290 0.0584
197 AGITATION 4286 0.0583
198 BLOOD TRIGLYCERIDES INCREASED 1028 0.0581
199 ALTERED STATE OF CONSCIOUSNESS 1259 0.0581
200 MULTIPLE DRUG OVERDOSE 288 0.0580
201 POLYDIPSIA 229 0.0579
202 HANGOVER 203 0.0577
203 SLOW SPEECH 140 0.0576
204 RESTLESSNESS 2106 0.0575
205 GLUCOSE TOLERANCE IMPAIRED 339 0.0573
206 DRUG SCREEN FALSE POSITIVE 158 0.0570
207 IMPULSIVE BEHAVIOUR 214 0.0570
208 FOOD ALLERGY 436 0.0564
209 STOMA SITE DISCHARGE 154 0.0562
210 SALIVARY HYPERSECRETION 562 0.0561
211 SUICIDAL IDEATION 5124 0.0559
212 PUSTULAR PSORIASIS 190 0.0553
213 ASPIRATION 605 0.0552
214 POTENTIATING DRUG INTERACTION 184 0.0548
215 RESPIRATORY DEPRESSION 672 0.0548
216 BEHAVIOUR DISORDER 295 0.0545
217 ANXIETY DISORDER 182 0.0544
218 JAUNDICE CHOLESTATIC 192 0.0543
219 DROOLING 375 0.0542
220 HYPERTHERMIA 413 0.0540
221 THERAPEUTIC PRODUCT EFFECT VARIABLE 208 0.0536
222 DRUG INTERACTION 8495 0.0535
223 SELF-INJURIOUS IDEATION 222 0.0529
224 FOOT DEFORMITY 584 0.0526
225 PSYCHOMOTOR HYPERACTIVITY 874 0.0526
226 MYOCLONUS 625 0.0524
227 FAECALOMA 287 0.0523
228 NEONATAL RESPIRATORY DISTRESS SYNDROME 185 0.0522
229 IMPAIRED HEALING 1713 0.0521
230 RED BLOOD CELL SEDIMENTATION RATE INCREASED 577 0.0521
231 THINKING ABNORMAL 966 0.0518
232 COMMUNICATION DISORDER 197 0.0515
233 ABNORMAL BEHAVIOUR 2022 0.0510
234 WRONG PATIENT RECEIVED PRODUCT 149 0.0509
235 ENURESIS 205 0.0507
236 ULCER HAEMORRHAGE 341 0.0503
237 HIP ARTHROPLASTY 760 0.0496
238 HOSTILITY 126 0.0495
239 MATERNAL EXPOSURE TIMING UNSPECIFIED 186 0.0495
240 DIABETIC RETINOPATHY 168 0.0494
241 EYE INJURY 150 0.0493
242 HYPERPHAGIA 196 0.0491
243 MYOCARDITIS 556 0.0485
244 SPONDYLITIS 176 0.0484
245 PANIC DISORDER 187 0.0482
246 HYPERGLYCAEMIA 1757 0.0482
247 HYPERTRIGLYCERIDAEMIA 282 0.0481
248 EUPHORIC MOOD 493 0.0481
249 DRUG SCREEN POSITIVE 376 0.0475
250 MYDRIASIS 607 0.0473
251 TROPONIN INCREASED 359 0.0471
252 DRUG TOLERANCE 238 0.0470
253 ALCOHOLISM 201 0.0469
254 FEELING OF DESPAIR 218 0.0467
255 PSYCHIATRIC SYMPTOM 344 0.0466
256 TRISMUS 239 0.0462
257 AFFECTIVE DISORDER 361 0.0459
258 ATRIAL SEPTAL DEFECT 382 0.0456
259 APATHY 659 0.0451
260 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 770 0.0449
261 EXPOSURE DURING PREGNANCY 2776 0.0446
262 ARTHROPATHY 2469 0.0444
263 PNEUMONIA ASPIRATION 1097 0.0439
264 DISSOCIATION 335 0.0437
265 MENTAL DISORDER 1886 0.0433
266 HEPATIC ENZYME INCREASED 2946 0.0432
267 INFUSION SITE REACTION 129 0.0431
268 ROAD TRAFFIC ACCIDENT 1806 0.0431
269 BRUXISM 232 0.0430
270 TENSION 261 0.0428
271 TOXIC ENCEPHALOPATHY 217 0.0428
272 DEMENTIA 1195 0.0427
273 TIC 233 0.0427
274 GAIT INABILITY 1425 0.0426
275 UNRESPONSIVE TO STIMULI 1096 0.0424
276 BLOOD CREATINE PHOSPHOKINASE INCREASED 1222 0.0424
277 PARADOXICAL DRUG REACTION 155 0.0421
278 BREAST CANCER STAGE II 349 0.0419
279 SOMNOLENCE 8446 0.0419
280 CONFUSIONAL STATE 6757 0.0418
281 RASH VESICULAR 202 0.0417
282 INCREASED APPETITE 791 0.0414
283 HYPERTONIA 237 0.0413
284 VENTRICULAR ARRHYTHMIA 151 0.0412
285 NIGHT SWEATS 1326 0.0411
286 HYPOTHERMIA 416 0.0410
287 OSTEOARTHRITIS 1740 0.0410
288 TORSADE DE POINTES 321 0.0409
289 DYSARTHRIA 1535 0.0407
290 HYPERSOMNIA 1165 0.0406
291 INCOHERENT 263 0.0406
292 SLEEP DISORDER 2856 0.0404
293 BRAIN INJURY 404 0.0403
294 SUDDEN CARDIAC DEATH 137 0.0401
295 ATRIOVENTRICULAR BLOCK FIRST DEGREE 174 0.0401
296 RHINITIS ALLERGIC 178 0.0399
297 APHAGIA 192 0.0399
298 SCREAMING 253 0.0397
299 ORTHOSTATIC HYPOTENSION 686 0.0394
300 HYPERAMMONAEMIA 197 0.0394
301 ILEUS PARALYTIC 175 0.0392
302 IMMUNODEFICIENCY 583 0.0391
303 OEDEMA 2104 0.0388
304 BUNDLE BRANCH BLOCK RIGHT 177 0.0385
305 NAIL DISORDER 337 0.0385
306 RESPIRATORY ARREST 1059 0.0384
307 RHABDOMYOLYSIS 1599 0.0383
308 LOWER RESPIRATORY TRACT INFECTION 1741 0.0382
309 CARDIO-RESPIRATORY ARREST 1599 0.0382
310 MENTAL IMPAIRMENT 926 0.0382
311 GRANULOCYTOPENIA 217 0.0381
312 FOOD CRAVING 200 0.0380
313 PANIC ATTACK 1385 0.0380
314 WEIGHT INCREASED 8495 0.0379
315 AFFECT LABILITY 365 0.0379
316 ANGER 1280 0.0378
317 HYPOKINESIA 549 0.0378
318 COLITIS ISCHAEMIC 252 0.0373
319 HEPATIC CIRRHOSIS 700 0.0372
320 CONGESTIVE CARDIOMYOPATHY 155 0.0372
321 ALCOHOL USE 135 0.0365
322 DISORIENTATION 1449 0.0365
323 DRUG DOSE OMISSION 6039 0.0365
324 TACHYCARDIA 3242 0.0365
325 WHEEZING 2141 0.0361
326 THERMAL BURN 256 0.0360
327 INFUSION RELATED REACTION 2383 0.0359
328 AMNESIA 2328 0.0357
329 RESPIRATORY ACIDOSIS 140 0.0356
330 DEPRESSION 8103 0.0356
331 DISCOMFORT 2172 0.0356
332 DYSPHEMIA 156 0.0355
333 OVERWEIGHT 191 0.0355
334 BRONCHIECTASIS 239 0.0354
335 HYPERNATRAEMIA 176 0.0353
336 ELECTROCARDIOGRAM ABNORMAL 277 0.0353
337 INSOMNIA 9378 0.0352
338 MATERNAL EXPOSURE DURING PREGNANCY 3136 0.0351
339 MOBILITY DECREASED 2527 0.0351
340 DRUG USE DISORDER 295 0.0351
341 INFARCTION 240 0.0350
342 INCONTINENCE 370 0.0350
343 DRUG LEVEL INCREASED 576 0.0348
344 SELF-MEDICATION 143 0.0348
345 URINARY RETENTION 1160 0.0347
346 MUSCULOSKELETAL STIFFNESS 3045 0.0347
347 NIGHTMARE 1195 0.0345
348 DRUG TOXICITY 470 0.0345
349 KNEE ARTHROPLASTY 723 0.0343
350 ATAXIA 407 0.0343
351 NONSPECIFIC REACTION 188 0.0342
352 SLEEP APNOEA SYNDROME 650 0.0340
353 COGNITIVE DISORDER 1581 0.0338
354 BLOOD LACTIC ACID INCREASED 178 0.0338
355 BLISTER 1889 0.0336
356 PULSELESS ELECTRICAL ACTIVITY 140 0.0335
357 INITIAL INSOMNIA 342 0.0333
358 COELIAC DISEASE 324 0.0330
359 STATUS EPILEPTICUS 372 0.0329
360 VENTRICULAR SEPTAL DEFECT 188 0.0328
361 FEELING OF BODY TEMPERATURE CHANGE 192 0.0327
362 SPEECH DISORDER 1713 0.0327
363 C-REACTIVE PROTEIN INCREASED 1184 0.0325
364 WITHDRAWAL SYNDROME 1365 0.0325
365 GENERALISED TONIC-CLONIC SEIZURE 536 0.0324
366 MUSCLE TWITCHING 746 0.0323
367 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 328 0.0319
368 BUNDLE BRANCH BLOCK LEFT 135 0.0318
369 DECREASED INTEREST 187 0.0317
370 EPILEPSY 966 0.0316
371 DISTURBANCE IN ATTENTION 1693 0.0314
372 DRY MOUTH 2539 0.0313
373 NYSTAGMUS 165 0.0311
374 DYSPHORIA 157 0.0310
375 BACK INJURY 337 0.0310
376 IRRITABILITY 1843 0.0306
377 PANCREATITIS ACUTE 684 0.0304
378 INJURY 2137 0.0304
379 GENERAL PHYSICAL HEALTH DETERIORATION 3509 0.0303
380 HAEMODYNAMIC INSTABILITY 230 0.0302
381 MENTAL STATUS CHANGES 835 0.0300
382 MOOD SWINGS 956 0.0300
383 THERAPEUTIC PRODUCT EFFECT DECREASED 1327 0.0296
384 NEPHROGENIC ANAEMIA 137 0.0295
385 RALES 171 0.0294
386 EYE MOVEMENT DISORDER 201 0.0293
387 DISABILITY 580 0.0293
388 HYPOTONIA 290 0.0290
389 APNOEA 226 0.0290
390 TREMOR 4816 0.0290
391 MOOD ALTERED 790 0.0289
392 ILL-DEFINED DISORDER 1746 0.0287
393 STOMATITIS 1742 0.0287
394 DRUG WITHDRAWAL SYNDROME NEONATAL 424 0.0286
395 ACTIVITIES OF DAILY LIVING IMPAIRED 562 0.0284
396 POOR QUALITY SLEEP 610 0.0283
397 SINUS BRADYCARDIA 273 0.0282
398 CONVULSION 1615 0.0282
399 DRUG INTOLERANCE 2725 0.0282
400 NEUROLOGICAL SYMPTOM 161 0.0281
401 BLOOD CHOLESTEROL ABNORMAL 130 0.0281
402 CRYING 1022 0.0281
403 MYOSITIS 252 0.0281
404 SUDDEN DEATH 297 0.0280
405 ANXIETY 7956 0.0279
406 DRUG LEVEL ABOVE THERAPEUTIC 128 0.0279
407 PANIC REACTION 201 0.0278
408 OVERDOSE 6001 0.0278
409 RHEUMATOID ARTHRITIS 3130 0.0275
410 ACIDOSIS 210 0.0275
411 GRAND MAL CONVULSION 253 0.0274
412 CIRCULATORY COLLAPSE 465 0.0273
413 MUSCULOSKELETAL PAIN 1429 0.0272
414 MOTOR DYSFUNCTION 277 0.0272
415 PRE-ECLAMPSIA 129 0.0271
416 POLYARTHRITIS 143 0.0271
417 THERAPY NON-RESPONDER 1217 0.0270
418 NORMAL NEWBORN 147 0.0270
419 COORDINATION ABNORMAL 377 0.0270
420 MEMORY IMPAIRMENT 3712 0.0270
421 DRUG LEVEL BELOW THERAPEUTIC 149 0.0270
422 SARCOIDOSIS 128 0.0269
423 DEPRESSED MOOD 1416 0.0268
424 LEUKOPENIA 1338 0.0267
425 LUNG DISORDER 1309 0.0267
426 URINARY INCONTINENCE 789 0.0266
427 FOETAL EXPOSURE DURING PREGNANCY 2162 0.0266
428 SWELLING 2485 0.0265
429 INTENTIONAL PRODUCT MISUSE 2318 0.0265
430 VENTRICULAR FIBRILLATION 294 0.0264
431 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1265 0.0263
432 ENCEPHALOPATHY 639 0.0260
433 OSTEOPOROSIS 1067 0.0259
434 TREATMENT NONCOMPLIANCE 1417 0.0259
435 DECUBITUS ULCER 211 0.0259
436 GENERAL SYMPTOM 194 0.0259
437 LOSS OF CONSCIOUSNESS 3315 0.0258
438 JOINT STIFFNESS 677 0.0258
439 TONGUE DISORDER 185 0.0255
440 POLYURIA 209 0.0255
441 FORMICATION 175 0.0251
442 LIVER DISORDER 1115 0.0251
443 REFUSAL OF TREATMENT BY PATIENT 164 0.0251
444 FEELING DRUNK 186 0.0250
445 LIVER FUNCTION TEST INCREASED 533 0.0248
446 BACK DISORDER 402 0.0247
447 WRONG PRODUCT ADMINISTERED 167 0.0247
448 HYPONATRAEMIA 1392 0.0247
449 TASTE DISORDER 496 0.0244
450 HEPATIC CYTOLYSIS 311 0.0244
451 EAR INFECTION 649 0.0244
452 CARDIAC MURMUR 211 0.0244
453 EATING DISORDER 519 0.0243
454 PREGNANCY 488 0.0243
455 CARDIAC ARREST 1999 0.0242
456 MEDICATION ERROR 1345 0.0242
457 OBSTRUCTIVE AIRWAYS DISORDER 269 0.0242
458 ARTERIOSCLEROSIS CORONARY ARTERY 160 0.0241
459 TREATMENT FAILURE 1994 0.0240
460 UPPER RESPIRATORY TRACT INFECTION 1109 0.0240
461 SLUGGISHNESS 244 0.0239
462 PRE-EXISTING CONDITION IMPROVED 149 0.0238
463 INTENTIONAL PRODUCT USE ISSUE 2084 0.0238
464 HYPERTENSION 4997 0.0236
465 EMOTIONAL DISORDER 725 0.0235
466 HYPERVENTILATION 135 0.0233
467 CONCUSSION 180 0.0232
468 APHASIA 699 0.0231
469 LEFT VENTRICULAR DYSFUNCTION 155 0.0231
470 AGRANULOCYTOSIS 425 0.0228
471 ABNORMAL WEIGHT GAIN 282 0.0228
472 GYNAECOMASTIA 705 0.0228
473 HEART RATE ABNORMAL 127 0.0228
474 ANAL INCONTINENCE 203 0.0225
475 FEAR 607 0.0225
476 WEIGHT FLUCTUATION 236 0.0225
477 CONTUSION 2168 0.0225
478 JOINT SWELLING 2716 0.0225
479 ABNORMAL DREAMS 617 0.0223
480 BRAIN OEDEMA 282 0.0223
481 TACHYPNOEA 301 0.0221
482 ERECTILE DYSFUNCTION 568 0.0221
483 HEAD INJURY 699 0.0221
484 EAR PAIN 426 0.0219
485 METABOLIC ACIDOSIS 700 0.0219
486 HYPOTHYROIDISM 697 0.0218
487 HYPOTENSION 4374 0.0218
488 ASPHYXIA 178 0.0218
489 MOVEMENT DISORDER 697 0.0217
490 FEELING JITTERY 412 0.0216
491 MUSCLE DISORDER 175 0.0216
492 CARDIOGENIC SHOCK 310 0.0216
493 MIDDLE INSOMNIA 403 0.0216
494 HYPERHIDROSIS 2766 0.0214
495 WHITE BLOOD CELL COUNT INCREASED 823 0.0214
496 HYPOGLYCAEMIA 1040 0.0214
497 HYPOKALAEMIA 983 0.0213
498 HYPOXIA 748 0.0212
499 SPUTUM DISCOLOURED 201 0.0212
500 MIGRAINE 2015 0.0211
501 SEIZURE 2438 0.0211
502 IMPAIRED GASTRIC EMPTYING 286 0.0210
503 APPETITE DISORDER 139 0.0209
504 THIRST 374 0.0209
505 WRONG DRUG ADMINISTERED 186 0.0208
506 SHOCK 480 0.0208
507 ASTHMA 2343 0.0207
508 HEPATIC STEATOSIS 385 0.0206
509 CONDITION AGGRAVATED 6280 0.0206
510 ABDOMINAL DISCOMFORT 3459 0.0206
511 INFLAMMATION 1064 0.0206
512 OEDEMA PERIPHERAL 2486 0.0204
513 ADVERSE DRUG REACTION 1828 0.0203
514 HYPOAESTHESIA 3017 0.0201
515 ACCIDENTAL OVERDOSE 737 0.0201
516 LETHARGY 1159 0.0201
517 IMPAIRED WORK ABILITY 430 0.0201
518 DYSGRAPHIA 132 0.0200
519 LOSS OF LIBIDO 180 0.0200
520 BODY TEMPERATURE INCREASED 407 0.0199
521 LEUKOCYTOSIS 360 0.0199
522 DRUG-INDUCED LIVER INJURY 623 0.0198
523 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 336 0.0198
524 INTERVERTEBRAL DISC DEGENERATION 182 0.0197
525 HUNGER 274 0.0197
526 SKIN LACERATION 213 0.0196
527 GASTROOESOPHAGEAL REFLUX DISEASE 1574 0.0195
528 SENSORY LOSS 157 0.0195
529 GAIT DISTURBANCE 3726 0.0194
530 FALL 6447 0.0194
531 PARALYSIS 276 0.0193
532 DYSPHAGIA 1830 0.0193
533 NERVOUSNESS 1007 0.0193
534 CONGENITAL ANOMALY 149 0.0192
535 RENAL FAILURE CHRONIC 147 0.0191
536 PAROSMIA 144 0.0191
537 MENSTRUAL DISORDER 158 0.0191
538 CYANOSIS 300 0.0191
539 ILEUS 237 0.0191
540 PRODUCT USE ISSUE 3581 0.0190
541 CARDIOMYOPATHY 281 0.0190
542 DYSURIA 699 0.0190
543 RESPIRATORY DISORDER 568 0.0190
544 ANHEDONIA 498 0.0189
545 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 167 0.0189
546 DRUG PRESCRIBING ERROR 362 0.0188
547 EMPHYSEMA 190 0.0188
548 VENTRICULAR TACHYCARDIA 311 0.0188
549 WRONG TECHNIQUE IN DRUG USAGE PROCESS 682 0.0188
550 DYSPEPSIA 1842 0.0187
551 ACCIDENT 223 0.0187
552 BALANCE DISORDER 1611 0.0186
553 ADVERSE EVENT 1713 0.0186
554 SPINAL OSTEOARTHRITIS 163 0.0185
555 HYPERTRANSAMINASAEMIA 129 0.0185
556 CHOLELITHIASIS 608 0.0185
557 BRADYCARDIA 982 0.0185
558 HYPOPHAGIA 473 0.0185
559 CARDIOTOXICITY 165 0.0185
560 THERAPEUTIC RESPONSE UNEXPECTED 826 0.0184
561 FLANK PAIN 172 0.0183
562 NEUTROPHIL COUNT INCREASED 187 0.0182
563 BLOOD SODIUM DECREASED 344 0.0182
564 IMPAIRED DRIVING ABILITY 207 0.0182
565 ARRHYTHMIA 860 0.0181
566 BLOOD CALCIUM INCREASED 159 0.0181
567 SINUSITIS 1858 0.0181
568 CHOKING 352 0.0180
569 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 463 0.0180
570 ELECTROLYTE IMBALANCE 209 0.0180
571 DECREASED ACTIVITY 193 0.0179
572 DRUG LEVEL DECREASED 182 0.0179
573 ECONOMIC PROBLEM 269 0.0177
574 DYSSTASIA 513 0.0176
575 DENTAL CARIES 194 0.0175
576 DRUG WITHDRAWAL SYNDROME 1528 0.0174
577 ANKLE FRACTURE 268 0.0173
578 FLUID RETENTION 879 0.0173
579 SUPRAVENTRICULAR TACHYCARDIA 165 0.0172
580 MATERNAL DRUGS AFFECTING FOETUS 132 0.0172
581 CHEST PAIN 3185 0.0172
582 ALOPECIA 3361 0.0171
583 INFECTION 2473 0.0171
584 CARDIOMEGALY 210 0.0171
585 SYNCOPE 1708 0.0171
586 CEREBRAL DISORDER 126 0.0170
587 PULMONARY CONGESTION 224 0.0170
588 BEDRIDDEN 223 0.0169
589 VENTRICULAR EXTRASYSTOLES 176 0.0169
590 BODY TEMPERATURE DECREASED 166 0.0168
591 FREQUENT BOWEL MOVEMENTS 454 0.0168
592 GASTROINTESTINAL DISORDER 1494 0.0167
593 ADRENAL INSUFFICIENCY 202 0.0166
594 MICTURITION URGENCY 190 0.0166
595 ACUTE RESPIRATORY DISTRESS SYNDROME 293 0.0165
596 PERIPHERAL SWELLING 2543 0.0165
597 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1173 0.0165
598 THYROID DISORDER 254 0.0165
599 FEELING ABNORMAL 3926 0.0164
600 BLOOD PRESSURE FLUCTUATION 392 0.0163
601 ARTERIOSCLEROSIS 153 0.0162
602 RESPIRATORY FAILURE 1182 0.0162
603 HIATUS HERNIA 209 0.0161
604 MUSCULAR WEAKNESS 1831 0.0161
605 DIZZINESS POSTURAL 156 0.0161
606 BLOOD TEST ABNORMAL 225 0.0160
607 RIB FRACTURE 329 0.0160
608 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 824 0.0158
609 CONSTIPATION 3436 0.0157
610 IRON DEFICIENCY ANAEMIA 145 0.0157
611 TRANSAMINASES INCREASED 347 0.0156
612 VERTIGO 944 0.0155
613 ACUTE KIDNEY INJURY 2369 0.0155
614 DECREASED APPETITE 3589 0.0154
615 MULTIPLE ORGAN DYSFUNCTION SYNDROME 435 0.0153
616 ATELECTASIS 148 0.0153
617 PULMONARY EMBOLISM 1453 0.0153
618 HEPATITIS C 184 0.0152
619 BLOOD POTASSIUM INCREASED 247 0.0152
620 NERVOUS SYSTEM DISORDER 474 0.0152
621 PRODUCT USE IN UNAPPROVED INDICATION 3762 0.0152
622 ACUTE RESPIRATORY FAILURE 292 0.0152
623 AMENORRHOEA 266 0.0152
624 HYPERSENSITIVITY 2813 0.0151
625 PNEUMONIA 4899 0.0151
626 GAMMA-GLUTAMYLTRANSFERASE INCREASED 335 0.0151
627 OXYGEN SATURATION DECREASED 848 0.0151
628 VOMITING 7058 0.0150
629 NASOPHARYNGITIS 2733 0.0148
630 ABDOMINAL PAIN UPPER 3047 0.0148
631 BRONCHITIS 1092 0.0147
632 HYPERTENSIVE CRISIS 164 0.0147
633 JOINT INJURY 314 0.0147
634 HAEMATOCRIT DECREASED 290 0.0146
635 CAESAREAN SECTION 170 0.0146
636 END STAGE RENAL DISEASE 266 0.0146
637 MALNUTRITION 163 0.0146
638 MUSCLE STRAIN 126 0.0145
639 PYREXIA 5038 0.0145
640 DIZZINESS 7245 0.0145
641 PARAESTHESIA 2274 0.0144
642 PALLOR 391 0.0144
643 WEIGHT DECREASED 4007 0.0143
644 OFF LABEL USE 12548 0.0143
645 MUSCLE SPASMS 2620 0.0143
646 INTERVERTEBRAL DISC PROTRUSION 311 0.0142
647 DIPLOPIA 369 0.0142
648 FEEDING DISORDER 288 0.0142
649 STAPHYLOCOCCAL INFECTION 467 0.0141
650 VITAMIN D DEFICIENCY 138 0.0141
651 PRESYNCOPE 344 0.0141
652 MYOCARDIAL ISCHAEMIA 161 0.0141
653 TOOTH ABSCESS 144 0.0141
654 HOSPICE CARE 139 0.0141
655 ALANINE AMINOTRANSFERASE INCREASED 862 0.0140
656 LACERATION 132 0.0140
657 CHRONIC KIDNEY DISEASE 1066 0.0140
658 UROSEPSIS 129 0.0140
659 FOOT FRACTURE 265 0.0140
660 HEART RATE INCREASED 1384 0.0140
661 MUSCLE TIGHTNESS 226 0.0139
662 LIMB INJURY 377 0.0139
663 RESPIRATORY DISTRESS 383 0.0139
664 BLOOD GLUCOSE FLUCTUATION 152 0.0139
665 NERVE INJURY 154 0.0138
666 BLOOD PRESSURE DECREASED 919 0.0138
667 HEAD DISCOMFORT 244 0.0138
668 ARTHRITIS 1083 0.0138
669 INSURANCE ISSUE 210 0.0137
670 QUALITY OF LIFE DECREASED 184 0.0137
671 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 752 0.0137
672 MALAISE 5984 0.0136
673 RECTAL HAEMORRHAGE 583 0.0136
674 NOCTURIA 164 0.0135
675 STEVENS-JOHNSON SYNDROME 300 0.0135
676 RASH ERYTHEMATOUS 643 0.0134
677 COLD SWEAT 234 0.0133
678 BLOOD LACTATE DEHYDROGENASE INCREASED 210 0.0132
679 PRODUCT ADMINISTRATION ERROR 267 0.0132
680 SWOLLEN TONGUE 410 0.0131
681 NEUROTOXICITY 229 0.0131
682 LIVER FUNCTION TEST ABNORMAL 380 0.0131
683 VISUAL IMPAIRMENT 1615 0.0130
684 SENSORY DISTURBANCE 209 0.0130
685 WRIST FRACTURE 156 0.0130
686 URTICARIA 2178 0.0130
687 PREMATURE BABY 391 0.0130
688 DECREASED IMMUNE RESPONSIVENESS 127 0.0129
689 PHARYNGITIS 160 0.0129
690 EOSINOPHILIA 226 0.0129
691 ANGINA PECTORIS 369 0.0129
692 GASTRITIS 337 0.0128
693 HEPATOTOXICITY 285 0.0128
694 TINNITUS 588 0.0128
695 HAEMATEMESIS 324 0.0128
696 ABDOMINAL PAIN 2969 0.0127
697 ASTHENIA 4789 0.0127
698 URINARY TRACT INFECTION 2169 0.0127
699 FEELING HOT 776 0.0126
700 HEART RATE IRREGULAR 285 0.0126
701 PULMONARY OEDEMA 564 0.0126
702 DEVICE OCCLUSION 177 0.0126
703 DRUG DISPENSING ERROR 192 0.0125
704 BLOOD CREATININE INCREASED 819 0.0125
705 BLOOD PRESSURE SYSTOLIC INCREASED 244 0.0125
706 BLOOD BILIRUBIN INCREASED 337 0.0125
707 FEELING COLD 347 0.0125
708 DEHYDRATION 1662 0.0124
709 MITRAL VALVE INCOMPETENCE 141 0.0124
710 ASPARTATE AMINOTRANSFERASE INCREASED 658 0.0124
711 HEPATOCELLULAR INJURY 175 0.0123
712 INTESTINAL OBSTRUCTION 465 0.0123
713 NECK PAIN 689 0.0123
714 HYPOAESTHESIA ORAL 184 0.0122
715 ABORTION SPONTANEOUS 489 0.0122
716 NEUROPATHY PERIPHERAL 1160 0.0122
717 RENAL FAILURE 1616 0.0122
718 BODY HEIGHT DECREASED 130 0.0121
719 PRODUCT PRESCRIBING ERROR 289 0.0121
720 GASTROENTERITIS 177 0.0121
721 THERAPEUTIC RESPONSE DECREASED 734 0.0121
722 PALPITATIONS 1412 0.0120
723 HIP FRACTURE 387 0.0120
724 FATIGUE 9365 0.0120
725 ABASIA 297 0.0120
726 MUSCULOSKELETAL CHEST PAIN 186 0.0120
727 RETCHING 256 0.0120
728 TRANSIENT ISCHAEMIC ATTACK 405 0.0120
729 POLLAKIURIA 497 0.0119
730 GASTROENTERITIS VIRAL 214 0.0118
731 PAIN 7278 0.0118
732 HYPOCALCAEMIA 224 0.0118
733 VISION BLURRED 1615 0.0118
734 CYSTITIS 373 0.0117
735 BLOOD UREA INCREASED 196 0.0117
736 PHOTOSENSITIVITY REACTION 193 0.0117
737 HEPATITIS 299 0.0117
738 DRUG EXPOSURE DURING PREGNANCY 396 0.0116
739 THROMBOCYTOPENIA 1299 0.0116
740 LIMB DISCOMFORT 359 0.0116
741 GASTRIC ULCER 220 0.0116
742 HEPATIC FUNCTION ABNORMAL 432 0.0116
743 NEUTROPENIA 1573 0.0116
744 ANOREXIA 149 0.0116
745 HEART RATE DECREASED 405 0.0115
746 DEEP VEIN THROMBOSIS 746 0.0115
747 BLOOD ALKALINE PHOSPHATASE INCREASED 283 0.0114
748 ULCER 181 0.0114
749 HEADACHE 7088 0.0113
750 PERICARDIAL EFFUSION 261 0.0113
751 HAEMORRHOIDS 220 0.0113
752 IMPAIRED QUALITY OF LIFE 162 0.0113
753 CHOLESTASIS 216 0.0112
754 REBOUND EFFECT 127 0.0112
755 MUSCLE SPASTICITY 138 0.0112
756 HEMIPARESIS 190 0.0112
757 BACTERIAL INFECTION 208 0.0111
758 LACTIC ACIDOSIS 360 0.0111
759 POLYNEUROPATHY 133 0.0111
760 UPPER LIMB FRACTURE 221 0.0111
761 NEURALGIA 269 0.0111
762 SEPTIC SHOCK 475 0.0109
763 GALLBLADDER DISORDER 194 0.0109
764 ACUTE HEPATIC FAILURE 148 0.0108
765 NODULE 141 0.0108
766 TOXIC EPIDERMAL NECROLYSIS 164 0.0108
767 HYPERKALAEMIA 377 0.0107
768 COLITIS ULCERATIVE 480 0.0107
769 PLATELET COUNT INCREASED 140 0.0107
770 SMALL INTESTINAL OBSTRUCTION 132 0.0107
771 CARPAL TUNNEL SYNDROME 150 0.0107
772 HEPATIC FAILURE 322 0.0107
773 BLOOD POTASSIUM DECREASED 321 0.0107
774 PULMONARY MASS 159 0.0107
775 DRUG ERUPTION 189 0.0107
776 HYPERTHYROIDISM 154 0.0106
777 NAUSEA 8414 0.0106
778 OSTEOPENIA 161 0.0106
779 CORONARY ARTERY DISEASE 321 0.0106
780 RENAL FAILURE ACUTE 449 0.0106
781 PHOTOPHOBIA 199 0.0106
782 THERAPY PARTIAL RESPONDER 165 0.0106
783 RASH 4607 0.0106
784 FRACTURE 200 0.0106
785 PAIN IN EXTREMITY 3101 0.0105
786 UNDERDOSE 768 0.0105
787 PSORIASIS 1365 0.0104
788 BRAIN FOG 163 0.0104
789 BLOOD PRESSURE INCREASED 1589 0.0104
790 RENAL DISORDER 482 0.0103
791 SUBDURAL HAEMATOMA 147 0.0103
792 JAUNDICE 274 0.0102
793 DERMATITIS ALLERGIC 128 0.0102
794 ORAL CANDIDIASIS 133 0.0101
795 NEUTROPHIL COUNT DECREASED 411 0.0101
796 ARTHRALGIA 4176 0.0100
797 DRUG INEFFECTIVE 13097 0.0099
798 HAEMOPTYSIS 277 0.0099
799 DYSPNOEA 5615 0.0099
800 BLOOD GLUCOSE ABNORMAL 182 0.0098
801 FACE OEDEMA 165 0.0098
802 BACK PAIN 2260 0.0097
803 GLAUCOMA 187 0.0097
804 DRUG RESISTANCE 249 0.0097
805 CARDIAC FAILURE 778 0.0097
806 WHITE BLOOD CELL COUNT DECREASED 1046 0.0096
807 TOOTH LOSS 200 0.0096
808 RESPIRATORY TRACT INFECTION 249 0.0096
809 MELAENA 209 0.0095
810 CARDIAC DISORDER 888 0.0095
811 LABORATORY TEST ABNORMAL 280 0.0095
812 CATARACT 565 0.0095
813 THROAT TIGHTNESS 256 0.0095
814 PLEURAL EFFUSION 572 0.0094
815 INFLUENZA LIKE ILLNESS 771 0.0094
816 BLOOD GLUCOSE INCREASED 1757 0.0093
817 BLOOD PRESSURE ABNORMAL 185 0.0093
818 CARDIOVASCULAR DISORDER 236 0.0093
819 MOUTH ULCERATION 195 0.0092
820 ISCHAEMIC STROKE 165 0.0092
821 RED BLOOD CELL COUNT DECREASED 263 0.0092
822 CELLULITIS 463 0.0092
823 TOOTHACHE 166 0.0092
824 TUBULOINTERSTITIAL NEPHRITIS 171 0.0091
825 RENAL IMPAIRMENT 763 0.0091
826 HAEMATOMA 235 0.0091
827 VISUAL ACUITY REDUCED 298 0.0090
828 COAGULOPATHY 149 0.0089
829 NASAL CONGESTION 525 0.0089
830 RENAL INJURY 265 0.0089
831 ABDOMINAL DISTENSION 926 0.0089
832 DIARRHOEA 5723 0.0089
833 EMOTIONAL DISTRESS 1069 0.0088
834 OROPHARYNGEAL PAIN 815 0.0088
835 UPPER GASTROINTESTINAL HAEMORRHAGE 148 0.0088
836 TOOTH DISORDER 195 0.0088
837 KIDNEY INFECTION 172 0.0088
838 PRODUCTIVE COUGH 416 0.0087
839 ANAEMIA 1655 0.0087
840 CLOSTRIDIUM DIFFICILE INFECTION 189 0.0086
841 SEPSIS 951 0.0085
842 MUSCULOSKELETAL DISORDER 162 0.0085
843 EJECTION FRACTION DECREASED 132 0.0085
844 EYE DISORDER 279 0.0085
845 MUSCULOSKELETAL DISCOMFORT 146 0.0085
846 PHARYNGEAL OEDEMA 129 0.0084
847 CANDIDA INFECTION 141 0.0083
848 MYALGIA 1402 0.0082
849 BLINDNESS 333 0.0082
850 HERNIA 158 0.0082
851 PRODUCT SUBSTITUTION ISSUE 469 0.0081
852 CEREBRAL INFARCTION 198 0.0081
853 INTERNATIONAL NORMALISED RATIO INCREASED 231 0.0081
854 THERAPEUTIC RESPONSE SHORTENED 268 0.0081
855 EYE PAIN 455 0.0081
856 GASTRIC DISORDER 274 0.0080
857 PRURITUS 3065 0.0080
858 CEREBROVASCULAR ACCIDENT 1348 0.0079
859 DRUG DEPENDENCE 1279 0.0079
860 SCAR 136 0.0079
861 CHROMATURIA 179 0.0079
862 SKIN LESION 217 0.0079
863 CHILLS 925 0.0079
864 RASH MACULO-PAPULAR 175 0.0079
865 UNEVALUABLE EVENT 595 0.0079
866 HAEMATOCHEZIA 431 0.0078
867 PRODUCT PRESCRIBING ISSUE 169 0.0077
868 PANCYTOPENIA 433 0.0077
869 SPINAL FRACTURE 154 0.0077
870 SKIN DISCOLOURATION 353 0.0077
871 ACUTE MYOCARDIAL INFARCTION 226 0.0077
872 CEREBRAL HAEMORRHAGE 274 0.0076
873 LYMPHOCYTE COUNT DECREASED 135 0.0076
874 HOSPITALISATION 1171 0.0076
875 RASH PRURITIC 410 0.0076
876 LYMPHADENOPATHY 266 0.0075
877 NEPHROLITHIASIS 344 0.0075
878 CHEST DISCOMFORT 766 0.0075
879 PULMONARY HYPERTENSION 155 0.0074
880 PELVIC PAIN 135 0.0074
881 DRUG EFFECT DECREASED 398 0.0074
882 SWELLING FACE 481 0.0074
883 BURNING SENSATION 512 0.0073
884 HAEMATURIA 250 0.0073
885 MULTI-ORGAN FAILURE 126 0.0073
886 DYSPHONIA 426 0.0073
887 INFLUENZA 810 0.0073
888 THERAPY CESSATION 370 0.0072
889 HAEMOGLOBIN DECREASED 736 0.0072
890 BLOOD URINE PRESENT 136 0.0072
891 DISEASE RECURRENCE 338 0.0071
892 DYSPNOEA EXERTIONAL 265 0.0070
893 PRODUCT DISPENSING ERROR 152 0.0070
894 ORAL PAIN 156 0.0070
895 PAIN IN JAW 197 0.0069
896 DEATH 5953 0.0069
897 ABDOMINAL PAIN LOWER 174 0.0069
898 INTENTIONAL DOSE OMISSION 196 0.0069
899 SKIN DISORDER 228 0.0068
900 DEVICE DISLOCATION 296 0.0068
901 FUNGAL INFECTION 225 0.0067
902 ATRIAL FIBRILLATION 656 0.0067
903 RHINORRHOEA 433 0.0067
904 LIP SWELLING 222 0.0067
905 DRUG ADMINISTRATION ERROR 204 0.0066
906 SINUS DISORDER 131 0.0066
907 PRODUCT AVAILABILITY ISSUE 150 0.0066
908 RASH GENERALISED 170 0.0066
909 COUGH 1826 0.0065
910 CARDIAC FAILURE CONGESTIVE 522 0.0065
911 MYOCARDIAL INFARCTION 1132 0.0065
912 HOT FLUSH 485 0.0064
913 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 456 0.0064
914 DRY EYE 318 0.0064
915 LOCALISED INFECTION 154 0.0064
916 FAECES DISCOLOURED 138 0.0064
917 FEMUR FRACTURE 197 0.0064
918 MULTIPLE SCLEROSIS 304 0.0064
919 VIRAL INFECTION 211 0.0063
920 GLYCOSYLATED HAEMOGLOBIN INCREASED 159 0.0063
921 GASTROINTESTINAL HAEMORRHAGE 511 0.0061
922 FLATULENCE 346 0.0061
923 DEAFNESS 157 0.0060
924 PRODUCT QUALITY ISSUE 815 0.0060
925 ANGIOEDEMA 265 0.0060
926 ASCITES 176 0.0060
927 THROMBOSIS 481 0.0060
928 RASH MACULAR 206 0.0059
929 EPISTAXIS 438 0.0058
930 ILLNESS 603 0.0058
931 INCORRECT DOSE ADMINISTERED 1328 0.0058
932 DIVERTICULITIS 161 0.0058
933 SKIN ULCER 149 0.0058
934 PLATELET COUNT DECREASED 608 0.0057
935 COLITIS 212 0.0056
936 PRODUCT DOSE OMISSION ISSUE 1638 0.0056
937 ERYTHEMA 1120 0.0054
938 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 965 0.0053
939 DYSGEUSIA 395 0.0053
940 PRODUCT DOSE OMISSION 346 0.0053
941 BONE PAIN 308 0.0053
942 THROAT IRRITATION 235 0.0052
943 LUNG NEOPLASM MALIGNANT 211 0.0051
944 DRUG EFFECT INCOMPLETE 186 0.0051
945 BLOOD GLUCOSE DECREASED 245 0.0051
946 MENSTRUATION IRREGULAR 136 0.0051
947 ECZEMA 265 0.0051
948 EYE SWELLING 188 0.0050
949 HAEMORRHAGE 523 0.0050
950 SURGERY 293 0.0050
951 PNEUMONITIS 134 0.0049
952 MULTIPLE SCLEROSIS RELAPSE 332 0.0048
953 LACRIMATION INCREASED 144 0.0048
954 HYPOACUSIS 205 0.0048
955 VAGINAL HAEMORRHAGE 198 0.0046
956 COVID-19 797 0.0045
957 PRODUCT DOSE OMISSION IN ERROR 128 0.0045
958 BONE DENSITY DECREASED 139 0.0044
959 OCULAR HYPERAEMIA 206 0.0043
960 HERPES ZOSTER 246 0.0043
961 DEVICE ISSUE 383 0.0043
962 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 144 0.0043
963 FEBRILE NEUTROPENIA 282 0.0042
964 INJECTION SITE MASS 156 0.0042
965 ANAPHYLACTIC REACTION 233 0.0042
966 NEOPLASM MALIGNANT 279 0.0042
967 INTERSTITIAL LUNG DISEASE 198 0.0041
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 826 0.0041
969 FLUSHING 409 0.0040
970 SKIN EXFOLIATION 334 0.0040
971 INJECTION SITE REACTION 258 0.0037
972 EXTRA DOSE ADMINISTERED 150 0.0037
973 EYE IRRITATION 212 0.0037
974 PRODUCT ADHESION ISSUE 126 0.0035
975 ACNE 256 0.0034
976 THERAPY INTERRUPTED 235 0.0033
977 DRY SKIN 395 0.0030
978 DISEASE PROGRESSION 342 0.0029
979 DEPENDENCE 156 0.0028
980 NO ADVERSE EVENT 455 0.0025
981 SKIN BURNING SENSATION 176 0.0025
982 INJECTION SITE PAIN 714 0.0023
983 INJECTION SITE SWELLING 165 0.0022
984 INJECTION SITE BRUISING 163 0.0020
985 ACCIDENTAL EXPOSURE TO PRODUCT 209 0.0020
986 BREAST CANCER 185 0.0020
987 INJECTION SITE ERYTHEMA 231 0.0019
988 INJECTION SITE HAEMORRHAGE 146 0.0018
989 DEVICE MALFUNCTION 128 0.0018
990 MALIGNANT NEOPLASM PROGRESSION 139 0.0014